These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23046367)

  • 41. Dialyzer membrane permeability and survival in hemodialysis patients.
    Chauveau P; Nguyen H; Combe C; ChĂȘne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
    Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of a vascular access nurse coordinator to reduce central venous catheter use in incident hemodialysis patients: a quality improvement report.
    Polkinghorne KR; Seneviratne M; Kerr PG
    Am J Kidney Dis; 2009 Jan; 53(1):99-106. PubMed ID: 18805614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study of dialysis outcomes and practice patterns].
    Saito A; Marumo F; Kurokawa K
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():633-40. PubMed ID: 15250381
    [No Abstract]   [Full Text] [Related]  

  • 44. Early start of combination therapy with hemodialysis and peritoneal dialysis prolongs survival and reduces cardiovascular events in male patients.
    Suzuki H; Hoshi H; Inoue T; Kikuta T; Tsuda M; Takenaka T
    Adv Perit Dial; 2012; 28():68-73. PubMed ID: 23311217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Peritoneal dialysis in the treatment of chronic renal failure].
    Kazimirov VG; Butrin SV; Bekov RR; Sapozhnikov AD; Kharitonov BI; Smoliakov AM; Detinenko IN
    Urologiia; 2004; (5):58-62. PubMed ID: 15560166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peritoneal dialysis is not a superior therapy to hemodialysis: a comparison.
    Stokes JB
    Blood Purif; 2012; 33(1-3):160-4. PubMed ID: 22269603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil.
    Sesso R; da Silva CB; Kowalski SC; Manfredi SR; Canziani ME; Draibe SA; Elgazzar HA; Ferraz MB
    Int J Technol Assess Health Care; 2007; 23(1):126-30. PubMed ID: 17234026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of extended-hours home hemodialysis and buttonhole cannulation technique on hospitalization rates for septic events related to dialysis access.
    Van Eps CL; Jones M; Ng T; Johnson DW; Campbell SB; Isbel NM; Mudge DW; Beller E; Hawley CM
    Hemodial Int; 2010 Oct; 14(4):451-63. PubMed ID: 20955279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pro: the arteriovenous fistula is a blessing of God.
    Basile C; Lomonte C
    Nephrol Dial Transplant; 2012 Oct; 27(10):3752-6. PubMed ID: 22474210
    [No Abstract]   [Full Text] [Related]  

  • 50. Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.
    Shoji T; Nishizawa Y
    Ther Apher Dial; 2006 Aug; 10(4):305-15. PubMed ID: 16911182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular problems in dialysis patients: impact on survival.
    Sidhu MS; Dellsperger KC
    Adv Perit Dial; 2010; 26():47-52. PubMed ID: 21348379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of care assessment and adherence to the international guidelines considering dialysis, water treatment, and protection against transmission of infections in university hospital-based dialysis units in Cairo, Egypt.
    Ibrahim S
    Hemodial Int; 2010 Jan; 14(1):61-7. PubMed ID: 19758297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dialysis therapy.
    Pastan S; Bailey J
    N Engl J Med; 1998 May; 338(20):1428-37. PubMed ID: 9580651
    [No Abstract]   [Full Text] [Related]  

  • 54. Dialysis adequacy and Kidney Disease Outcomes Quality Initiative goals achievement in an Iranian hemodialysis population.
    Malekmakan L; Haghpanah S; Pakfetrat M; Malekmakan A; Alimanesh M; Haghpanah A; Khajedehi P
    Iran J Kidney Dis; 2010 Jan; 4(1):39-43. PubMed ID: 20081303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors influencing long-term survival in patients on chronic dialysis.
    Iseki K; Shinzato T; Nagura Y; Akiba T
    Clin Exp Nephrol; 2004 Jun; 8(2):89-97. PubMed ID: 15235924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Attainment of the Japanese Society for Dialysis Therapy guidelines for the management of secondary hyperparathyroidism in chronic hemodialysis patients in our clinic.
    Sato Y; Eriguchi R; Umakoshi J; Kato M
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S48-53. PubMed ID: 17976086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
    Kazama JJ
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S44-7. PubMed ID: 17976085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology.
    Jindal K; Chan CT; Deziel C; Hirsch D; Soroka SD; Tonelli M; Culleton BF;
    J Am Soc Nephrol; 2006 Mar; 17(3 Suppl 1):S1-27. PubMed ID: 16497879
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapy for cardiovascular disease in dialysis patients.
    Ring T
    Kidney Int; 2000 Feb; 57(2):740-1. PubMed ID: 10712120
    [No Abstract]   [Full Text] [Related]  

  • 60. Frequent versus standard hemodialysis.
    Badve SV; Hawley CM; Johnson DW
    N Engl J Med; 2011 Mar; 364(10):975; author reply 976. PubMed ID: 21388319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.